Join us

Searched Tag: covaxin

Controversial Covaxin study faces retraction after ICMR objection. Image X.

ICMR demands retraction of erroneous Covaxin research

May 20, 2024, 06:13 PM - 2 min read

The Indian Council of Medical Research (ICMR) has disassociated itself from a study on the Covaxin vaccine, citing serious methodological flaws and an erroneous acknowledgment of ICMR's support.

Bharat Biotech defends Covaxin's safety amid BHU study findings

May 17, 2024, 12:30 PM - 2 min read

The BHU study, conducted between January 2022 and August 2023, found that serious AESIs, including stroke and Guillain-Barre syndrome, were reported in 1 percent of the individuals. The study highlighted that nearly 50 percent of participants experienced infections during the follow-up period, predominantly viral upper respiratory tract infections.

Covaxin is Very Safe Reaffirms Bharat Biotech. Image X.

Covaxin prioritises 'Safety First', says Bharat Biotech amid International Vaccine's safety discussions

May 2, 2024, 07:56 PM - 2 min read

Amid concerns surrounding the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, the developer of Covaxin, underscores its commitment to safety, emphasising that Covaxin was developed with a primary focus on safety first.